Table 2 Cost-effectiveness results of probabilistic sensitivity analysis
Healthcare system perspective | |||
|---|---|---|---|
| Â | Trastuzumab-CT regimen | CT only regimen | Difference |
Total Lifetime Cost (PHP) | 4,462,407 | 4,010,279 | 452,128 |
Total LYs gained | 11.07 | 9.87 | 1.20 |
Total QALYs gained | 8.99 | 7.99 | 1.00 |
ICER (PHP per LY gained) | 377,009 | ||
ICER (PHP per QALY gained) | 453,505 | ||